Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Visa Honkanen"'
Autor:
Kati P Markula-Patjas, Liisa Kerttula, Irma H Soini, Visa Honkanen, Outi Mäkitie, Sanna-Maria Toiviainen-Salo, Helena L Valta
Publikováno v:
The Journal of Rheumatology. 39:365-373
Objective.Vertebral fractures occur in patients with juvenile idiopathic arthritis (JIA), but data on their frequency and causes are scarce. Our cross-sectional study evaluated prevalence of compression fractures and associated factors in a high-risk
Autor:
Erkki Komulainen, Yrjö T. Konttinen, Visa Honkanen, Katariina Tamm, Hanna Vuorimaa, Nina Santavirta
Publikováno v:
Children's Health Care. 40:34-52
The purpose of this study was to identify the associations between parental and child psychosocial factors and pain in juvenile idiopathic arthritis (JIA). The sample comprised 142 patients with JIA and the attending parent. Explorative factor analys
Publikováno v:
Annals of the Rheumatic Diseases. 68:552-557
Objectives:To evaluate drug survival (continuation rates on drug) of anti-tumour necrosis factor (TNF) agents in juvenile idiopathic arthritis (JIA) and predictors for treatment discontinuation.Methods:A retrospective observational study on JIA patie
Autor:
K Kotaniemi, Kristiina Aalto, Pekka Lahdenne, Pirjo Tynjälä, Katariina Latva, Visa Honkanen, P Lindahl
Publikováno v:
Rheumatology. 47:339-344
Objective. To evaluate the efficacy of adalimumab in juvenile idiopathic arthritis (JIA)-associated uveitis. Methods. Retrospective observational study of 20 patients with JIA and chronic uveitis on adalimumab treatment. The ocular inflammation and i
Publikováno v:
Annals of the Rheumatic Diseases. 65:1044-1049
To evaluate the impact of anti-tumour necrosis factor (TNF) treatment on growth and to identify the predictors for the change in growth in severe juvenile idiopathic arthritis (JIA).Data from 71 JIA patients (43 on etanercept, 28 on infliximab) were
Biological treatment in rheumatic diseases: results from a longitudinal surveillance: adverse events
Autor:
J. Pöllänen, M. Romu, M. Vasala, M. Waahtera, L. Konttinen, Anna Karjalainen, R. Luukkainen, Kari Puolakka, T. Uotila, Visa Honkanen, Dan Nordström
Publikováno v:
Rheumatology International. 26:916-922
The objective of this study was to assess the long-term safety and tolerability of biologicals in a clinical setting. Data on adverse events (AEs) have been collected over a 5-year period by means of detailed reports sent in to the National Register
Autor:
Rik Joos, Susan Nielsen, Visa Honkanen, Kevin J. Murray, Dimitrina Mihaylova, Vibke Lilleby, Nicolino Ruperto, Huri Ozdogan, Anne M. Reed, Robert M. Rennebohm, Florence Kanakoudi, Rubén Burgos-Vargas, Edward H. Giannini, Kharaman Pagava, Elena Tsitsami, Wietse Kuis, Miroslav Harjacek, Claudio Machado, Carmen De Cunto, Zsolt Balogh, Michael Hofer, Anna Maria Romicka, Earl D. Silverman, Daniel J. Lovell, Richard Vesely, Lisa G. Rider, Sang Cheol Bae, Christian Huemer, I. Rumba, Lauren M. Pachman, P Woo, Pavla Dolezalova, Alberto Martini, Gordana Susic, Irina Nikishina, Philip J. Hashkes, AM Prieur, Madeleine Rooney, Jaime de Inocencio, Hans Iko Huppertz, Stella Garay, José Melo-Gomes, Angelo Ravelli, Brian M. Feldman, Boel Andersson-Gäre
Publikováno v:
Rheumatology. 42:1452-1459
To identify preliminary core sets of outcome variables for disease activity and damage assessment in juvenile systemic lupus erythematosus (JSLE) and juvenile dermatomyositis (JDM).Two questionnaire surveys were mailed to 267 physicians from 46 diffe
Publikováno v:
Annals of the Rheumatic Diseases. 66:548-550
Objective: To evaluate the efficacy of anti-tumour necrosis factor (anti-TNF) treatment in juvenile idiopathic arthritis (JIA)-associated uveitis. Methods: 24 patients with uveitis taking etanercept and 21 taking infliximab were studied. The endpoint
Publikováno v:
Rheumatology International. 14:231-234
In rheumatoid arthritis various pro-inflammatory metabolites of arachidonic acid (AA), such as leukotriene B4 (LTB4) and prostaglandin E2 (PGE2), contribute to tissue destruction and pain. In contrast to AA, which is an omega-6 fatty acid, the omega-
Autor:
O Vaarala, M Sidoroff, Olli A. Jänne, Visa Honkanen, K-L Kolho, Taneli Raivio, H Rintamäki, K Tamm
Publikováno v:
Scandinavian journal of rheumatology. 40(5)
To study the systemic effects of intra-articular (IA) glucocorticoid (GC) injections in juvenile idiopathic arthritis (JIA).The study group comprised 21 JIA patients being treated with IA methylprednisolone [MP (n = 15) or MP plus triamcinolone hexac